These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17125211)

  • 1. An integrated in silico analysis of drug-binding to human serum albumin.
    Estrada E; Uriarte E; Molina E; Simón-Manso Y; Milne GW
    J Chem Inf Model; 2006; 46(6):2709-24. PubMed ID: 17125211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico prediction of drug-binding strengths to human serum albumin.
    Colmenarejo G
    Med Res Rev; 2003 May; 23(3):275-301. PubMed ID: 12647311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative correlation between theoretical molecular descriptors and drug-HSA binding affinities for various cox-2 inhibitors.
    Seedher N; Bhatia S; Singh B
    Chem Biol Drug Des; 2008 Oct; 72(4):297-302. PubMed ID: 18844676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions.
    Deeb O; Rosales-Hernández MC; Gómez-Castro C; Garduño-Juárez R; Correa-Basurto J
    Biopolymers; 2010 Feb; 93(2):161-70. PubMed ID: 19785033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANN-QSAR model of drug-binding to human serum albumin.
    Deeb O; Hemmateenejad B
    Chem Biol Drug Des; 2007 Jul; 70(1):19-29. PubMed ID: 17630991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of daunomycin antibiotic with human serum albumin: investigation by resonant mirror biosensor technique, fluorescence spectroscopy and molecular modeling methods.
    Tang K; Qin YM; Lin AH; Hu X; Zou GL
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):404-10. PubMed ID: 15964731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography.
    Zhu L; Yang F; Chen L; Meehan EJ; Huang M
    J Struct Biol; 2008 Apr; 162(1):40-9. PubMed ID: 18258455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin.
    Yang F; Bian C; Zhu L; Zhao G; Huang Z; Huang M
    J Struct Biol; 2007 Feb; 157(2):348-55. PubMed ID: 17067818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies.
    Cui F; Qin L; Zhang G; Liu Q; Yao X; Lei B
    J Pharm Biomed Anal; 2008 Nov; 48(3):1029-36. PubMed ID: 18722067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of self-organizing neural networks in virtual screening and diversity selection.
    Selzer P; Ertl P
    J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification of bioisosteric functional groups.
    Ertl P
    Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
    Fujiwara S; Amisaki T
    Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of mitoxantrone with human serum albumin: spectroscopic and molecular modeling studies.
    Khan SN; Islam B; Yennamalli R; Sultan A; Subbarao N; Khan AU
    Eur J Pharm Sci; 2008 Dec; 35(5):371-82. PubMed ID: 18762252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic and molecular modeling studies on the binding of the flavonoid luteolin and human serum albumin.
    Jurasekova Z; Marconi G; Sanchez-Cortes S; Torreggiani A
    Biopolymers; 2009 Nov; 91(11):917-27. PubMed ID: 19603495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling drug albumin binding affinity with e-state topological structure representation.
    Hall LM; Hall LH; Kier LB
    J Chem Inf Comput Sci; 2003; 43(6):2120-8. PubMed ID: 14632464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of human serum albumin binding for drug leads.
    Vallianatou T; Lambrinidis G; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2013 May; 8(5):583-95. PubMed ID: 23461733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.